ABSTRACT Bovine parathyroid extract and two commercial preparations containing the first 34 amino acids of synthetic bovine parathyroid hormone [bPTH41-34)] produced dose-related hypotension in anesthetized rats. Dogs were 10 times more sensitive to the two bPTH41-34) preparations than were rats.
conclude that the direct vasodilatory action of bPTH preparations represents an intrinsic property of parathyroid hormone and that the hypotensive effect of this hormone is produced by part or all of the first NH2-terminal 34 amino acids.
The antidiuretic action of exogenous parathyroid preparations in the South American lungfish (Lepidosiren paradoxa) was described in a previous report (1) . Because renal function in lungfish is significantly affected by systemic blood pressure (2, 3), we suspected that the antidiuresis resulting from administration of parathyroid extracts might be related to a hypotensive action of this hormone. A vasodilatory action of parathyroid extract and the peptide containing the first 34 amino acids of synthetic bovine parathyroid hormone [bPTH-(1-34)] has been reported in dogs (4, 5) . This hypotensive action of parathyroid hormone (PTH) has not been confirmed in any other vertebrate species. Furthermore, it was not clear whether the hormone is itself hypotensive or whether its action is mediated through other endogenous vasoactive substances.
In a recent series of studies, we observed the vasodepressor actions of synthetic bPTH-(1-34) in the following vertebrates: the South American lungfish, the bullfrog, the water snake Natrix fasciata, and the domestic chicken (6) . In the present studies we investigated the specific hypotensive actions of bPTH in the laboratory white rat and the mongrel dog. A dose-related vasodepressor response was demonstrated with two preparations of synthetic bPTH-(1-34). In both rats and dogs, the hypotensive action of bPTH-(1-34) was not inhibited by a-or 3-adrenergic, cholinergic, or histaminergic blocking agents. Furthermore, vasodilation could be demonstrated by using dog kidneys in vitro and rat hindlimbs perfused in situ with mammalian Ringer's solutions. Helical strips of rabbit aorta were also relaxed by bPTH-(1-34). On the basis of these results we propose that mammalian PTH has an intrinsic direct vasodilatory action on the vascular system. The exact mechanism of this action remains to be demonstrated. (ii) Rats. Sprague-Dawley rats of both sexes, weighing between 100 and 200 g, were anesthetized with sodium pentobarbitol and the right carotid artery and jugular vein were cannulated with polyethylene tubing PE 50. bPTH was administered and blood pressure was recorded in the anesthetized animals as described above for dogs. The doses of bPTH-(1-34) used were 10, 20, 40, and 100 IU/kg.
MATERIALS AND METHODS
Abbreviations: PTH, parathyroid hormone (parathyrin); bPTH-(1-34), amino acid residues 1-34-of bovine PTH; IU, international units; MAP, mean arterial blood pressure.
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(iii) Pharmacological antagonist studies. Rats and dogs were prepared as outlined above. The effects of propranolol, phentolamine, atropine, and promethazine on the depressor action of PTH-(1-34) was established, an agonist was injected in an effective dose. The specific antagonist was then given slowly. As soon as the MAP stabilized, the same dose of agonist was given again. If the agonists' actions were blocked, a test dose of bPTH-(1-34) was then given immediately. In dogs, the test dose of bPTH-(1-34) was 5 IU/kg and in rats, 40 IU/kg. Isoproterenol (0.1 g/kg) was the f3-adrenergic agonist used and propranolol (2 mg/kg) was the antagonist. Norepinephrine (0.5 ag/kg) served as the a-adrenergic agonist and phentolamine (2mg/kg), the antagonist. Atropine (2 mg/kg) was used to block the action of methacholine (1 ,ug/kg). The antihistamine promethazine (2 mg/kg) was used to inhibit the depressor effect of histamine (1 Ag/kg). Each agonist-antagonist combination was tested in 5 dogs and 12 rats. Experiments In Vitro. (i) Dog kidney perfusion. Mongrel dogs of both sexes, weighing approximately 14 kg, were anesthetized with sodium pentobarbitol (30 mg/kg, intravenous). A midline incision was made in the abdomen and the kidneys were visualized. A clamp was then placed across the renal artery and vein near the descending aorta to ensure that a maximal length of the renal artery remained with the kidney. All vessels to the kidney were sectioned and the freed kidney was placed in cold heparinized lactate Ringer's solution at 40C. Cannulae were inserted into the renal artery (arteries), and the kidney was perfused with cold heparinized Ringer's solution. All accessory renal arteries were ligated. If the kidney was properly flushed after 10 min of perfusion (as determined by a blanched appearance), it was connected to a pulsatile pressure kidney preparation apparatus (Waters MOX 100 Tm renal transport system). If the kidney was not successfully flushed, it was not used. The flow rate through the kidney was determined by measuring the length of time required to deliver 20 ml of perfusate through the kidney. Flow rate measurements were made at 1-min intervals. If a stable flow rate was seen after 1'/2 to 2 hr. the kidney was considered acceptable for testing the action of bPTH-(1-34). Kidneys in which flow rates failed to stabilize were also discarded.
When a steady baseline flow rate was established, bolus injections of bPTH-(1-34) at doses of 10, 50, 100, and 200 IU were made into the arterial perfusion. A second dose of bPTH-(1-34) was not given until the kidney recovered from the previous injection. In total, four kidneys were successfully used to study the action of bPTH-(1-34).
(ii) Isolated rabbit aortas. New Zealand White rabbits of either sex weighing approximately 1 kg received daily injections of reserpine (0.3 mg/kg) for 7 days to deplete catecholamine stores. On the 8th day, the animals were stunned by a blow to the back of the head and exsanguinated. After thoracotomy, a section of the thoracic aorta between the aortic arch and the diaphragm was removed and placed in oxygenated Ringer's solution of the following composition (mM): NaCl, 154; KCI, 5.4; CaC12, 2.4; NaHCO3, 6.0; and glucose, 11.0. The aortas were cleaned of all fat and connective tissue and cut into helical strips according to the method of Furchgott (7). The aortic strip was then arranged in a tissue holder assembly and placed in a tissue chamber. The free end of the aorta was attached to a Grass FT 03 force displacement transducer by a silk thread. Isometric contractions were recorded on a Grass model 79 polygraph. Before exposure to drugs, each aorta preparation wAs equilibrated for 60 min under a resting tension of 2 g.
During the equilibration period, the aortic strips were washed every 15 min. The solution in the tissue chambers was continuously oxygenated with a gas mixture of 95% 02 and 5% CO2
and maintained at 370C.
After the equilibration period, vasoconstriction was induced by using the a-adrenergic agonist methoxamine (100 MM). When a steady tension was achieved, a cumulative dose-response curve for the vasodilatory effect of bPTH- (1-34) (Fig. 2A) , propranolol, atropine, phentolamine, and promethazine almost completely blocked the action of isoproterenol, methacholine, norepinephrine, and histamine, respectively. In each instance, however, the depressor response to Peninsula bPTH-(1-34) was undiminished. Although the blockade of the same agonists by the respective antagonists was not as complete in the rats, less than 50% of the agonistic action was evident after the administration of antagonists in each case. Once again, the action of Peninsula bPTH-(1-34) was unaffected (Fig. 2B ).
In the four successful dog kidney perfusion experiments, increased doses of Peninsula bPTH-(1-34) caused increasing vasodilation. The results of one such experiment are given in Fig. 3 . In that experiment, bolus injection of 10 IU of bPTH-(1-34) had no effect; 50 IU produced increased flow through the kidney for 4 In both rats and dogs, the depressor responses did not seem to be mediated through the a-and (B-adrenergic, cholinergic, lasted up to 17 min. It is important to note that the flow rate returned to the original level after the effect of bPTH- (1-34) subsided.
The helical strips of rabbit aorta were rather insensitive to bPTH. High doses were needed to produce minimal relaxation. Paired t tests show that 10 and 20 IU of bPTH-(1-34) per ml of bathing medium produced significant decreases in developed force. These data are summarized in Fig. 4 .
The rat hindlimb perfusion preparation in situ was far more sensitive to bPTH-(1-34) (Fig. 5) than the rabbit aortic strip. Charbon and his coworkers demonstrated, in a series of studies with dogs, that parathyroid extract produces dose-related hypotension (4, 5, 8) . He showed that the hormonal preparation caused significant increases in coeliac and renal blood flow (4, 8, 9) . In a later study, he used Beckman synthetic bPTH-(1-34) and found similar increases in hepatic, coeliac, and renal blood flow (5 In some of our recent comparative studies, we injected bovine parathyroid extract and synthetic bPTH-(1-34) into the South American lungfish and observed consistent dose-related antidiuresis (1) . We suggested that this renal effect might be related to changes in systemic blood pressure. A subsequent study re- vealed that PTH lowers blood pressure in the South American lungfish, the bullfrog, the water snake, the domestic chicken, and the laboratory white rat (6) The fact that bPTH-(1-34) caused vasodilation in the dog kidney and rat hindlimb perfused with Ringer's solution provides clear evidence that'bPTH-(1-34) is itself vasodilatory. The relaxation of rabbit aortic strip by bPTH-(1-34) further substantiates such a notion. In both perfused hindlimb and rabbit aortic strip preparations, an a agonist was used to produce vasoconstriction first. Because studies in vio on the dog and the rat show that a-adrenergic receptors are not involved in the action of bPTH-(1-34), the effects of bPTH-(1-4) in these two preparations are due to bPTH-(1-34) itself and are not due to inhibition of the a-adrenergic system. Furthermore, in the dog kidney perfusion, only Ringer's solution was used. bPTH-(1-34), however, still produced clear-cut vasodilation.
Both the dog kidney and rat hindlimb systems are more sensitive to bPTH-(1-34) than the rabbit aortic strip. This suggests that the main vasodilatory receptors for bPTH-(1-34) reside in the resistance vessels, i.e., the arterioles and venules. The rabbit thoracic aorta, being a capacitance vessel, responds poorly to the administration of bPTH-(1-34).
In conclusion, bPTH and bPTH-(1-34) are vasodilatory. This property is intrinsic in the molecule itself. The ability to lower blood pressure resides in the first 34 NH-terminal amino acids. We believe that this present series of studies provides the definitive proof of the direct vasodilatory action of PTH.
